Tollovid Every day™ by Coinbase Commerce
Cryptocurrency accepted embrace Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Bitcoin Money (BCH) and Litecoin (LTC)
New York, NY & Tel Aviv, Israel, Sept. 19, 2021 (GLOBE NEWSWIRE) — (by way of Blockchain Wire) Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and options firm with complete product choices, introduced that it’s now accepting Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Bitcoin Money (BCH) and Litecoin (LTC) as fee for the Firm’s proprietary 3CL protease inhibitor wellness merchandise Tollovid® and Tollovid Every day™. The Firm is ready to settle for these types of funds by its www.mytollovid.com web site when purchasers choose Coinbase Commerce because the type of fee at checkout.
“We imagine strongly that everybody ought to take Tollovid to help their immune operate throughout instances of serious immune problem and must be taking Tollovid Every day every day with the intention to keep constant, wholesome immune operate,” stated Gerald E. Commissiong, President & CEO of Todos Medical. “The flexibility to just accept broadly utilized cryptocurrency is a crucial step as we broaden our advertising and marketing efforts round our novel 3CL protease inhibitor wellness merchandise.”
Tollovid and Tollovid Every day are dietary complement merchandise which have each acquired Certificates of Free Sale from the U.S. Meals & Drug Administration (FDA), authorizing the advertising and marketing and sale of those merchandise in the US. The FDA has allowed the Firm to make two particular claims close to every product:
- Tollovid and Tollovid Every day assist to help and keep wholesome immune operate; and
- Tollovid and Tollovid Every day are 3CL protease inhibitors.
Tollovid is focused to prospects that want most immune help, whereas Tollovid Every day addresses prospects that require or may benefit from every day immune help. Each Tollovid and Tollovid Every day might be bought by way of subscription and now, using cryptocurrency
About Todos Medical Ltd.
Based in Rehovot, Israel with workplaces in New York Metropolis, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic options for the early detection of quite a lot of cancers. In 20201, Todos accomplished the acquisition of U.S.-based medical diagnostics firm Provista Diagnostics, Inc. to realize rights to its Alpharetta, Georgia-based CLIA/CAP licensed lab at the moment performing PCR COVID testing and Provista’s proprietary commercial-stage Videssa® breast most cancers blood take a look at. The Firm’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening expertise utilizing peripheral blood evaluation that deploys deep examination into most cancers’s affect on the immune system, in search of biochemical modifications in blood mononuclear cells and plasma. Todos’ two internally-developed cancer-screening assessments, TMB-1 and TMB-2, have acquired a CE mark in Europe. Todos is targeted on the commercialization of Videssa and can convey the TBIA assessments to market thereafter.
Todos has entered right into a three way partnership with NLC Pharma focusing on diagnostic and testing options to handle the COVID-19 pandemic. The Joint-Enterprise is pursuing the event of diagnostic assessments focusing on the 3CL protease, in addition to 3CL protease inhibitors that focus on a basic reproductive mechanism of coronaviruses. The Firm’s proprietary therapeutic candidate Tollovir™ is at the moment in a Part 2 scientific trial to deal with hospitalized COVID-19 sufferers in Israel, and is getting ready to provoke Part 2/3 scientific trials for each hospitalized and non-hospitalized sufferers in Israel.
Todos can be creating blood assessments for the early detection of neurodegenerative issues, reminiscent of Alzheimer’s illness. The Lymphocyte Proliferation Check (LymPro Check™) is a diagnostic blood take a look at that determines the flexibility of peripheral blood lymphocytes (PBLs) and monocytes to face up to an exogenous mitogenic stimulation that induces them to enter the cell cycle. It’s believed that sure ailments, most notably Alzheimer’s illness, are the results of compromised mobile equipment that results in aberrant cell cycle re-entry by neurons, which then results in apoptosis. LymPro is exclusive in the usage of peripheral blood lymphocytes as a surrogate for neuronal cell operate, suggesting a typical relationship between PBLs and neurons within the mind.
Todos can be distributing sure (COVID-19) testing supplies and provides to CLIA-certified labs in the US. The merchandise cowl a number of suppliers of PCR testing kits, extraction kits, automation supplies and provides, in addition to COVID-19 antibody and antigen testing kits.
For extra info, please go to https://www.todosmedical.com
Sure statements contained on this press launch might represent forward-looking statements. For instance, forward-looking statements are used when discussing our anticipated scientific improvement applications and scientific trials. These forward-looking statements are based mostly solely on present expectations of administration, and are topic to important dangers and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements, together with the dangers and uncertainties associated to the progress, timing, price, and outcomes of scientific trials and product improvement applications; difficulties or delays in acquiring regulatory approval or patent safety for product candidates; competitors from different biotechnology corporations; and our capability to acquire further funding required to conduct our analysis, improvement and commercialization actions. As well as, the next components, amongst others, may trigger precise outcomes to vary materially from these described within the forward-looking statements: modifications in expertise and market necessities; delays or obstacles in launching our scientific trials; modifications in laws; lack of ability to well timed develop and introduce new applied sciences, merchandise and functions; lack of validation of our expertise as we progress additional and lack of acceptance of our strategies by the scientific group; lack of ability to retain or entice key staff whose information is important to the event of our merchandise; unexpected scientific difficulties that will develop with our course of; higher price of ultimate product than anticipated; lack of market share and strain on pricing ensuing from competitors; and laboratory outcomes that don’t translate to equally good leads to actual settings, all of which may trigger the precise outcomes or efficiency to vary materially from these contemplated in such forward-looking statements. Besides as in any other case required by legislation, Todos Medical doesn’t undertake any obligation to publicly launch any revisions to those forward-looking statements to replicate occasions or circumstances after the date hereof or to replicate the prevalence of unanticipated occasions. For a extra detailed description of the dangers and uncertainties affecting Todos Medical, please discuss with its studies filed infrequently with the U.S. Securities and Change Fee.
Todos Medical, Ltd